Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Korczynski Sherry. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 7 reports have been logged. Activity tracked since 7 June 2024. The latest transaction was filed on 14 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Korczynski Sherry is a declarant linked to Aquestive Therapeutics, Inc. (XNAS), where the listed role is Chief Commercial Officer. There are 4 filings in total, and across the sampled recent filings the period runs from 2024-06-11 to 2026-06-09, with the transaction nature listed as Retenue fiscale and aggregate buy and sell amounts of EUR 0.